MedWatch

Media changes Lundbeck recommendation to "buy"

Swedish industry media Dagens Industri assess that Lundbeck is worth buying based on the financial year’s outlook but cautions: investments come with risks.

Photo: Jens Dresling/Politiken/Ritzau Scanpix

Lundbeck might be worth buying into based on the company’s projections for the full year, assesses Swedish industry media Dagens Industri, however noting that investing comes with risks.

The media has gone over Lundbeck with a fine-tooth comb and given the recommendation ”buy” in its analysis section under the title ”share of the week,” as reported by media Direkt.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs